🇺🇸 FDA
Patent

US 6787321

Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products

expired A61KA61K48/00A61K48/0058

Quick answer

US patent 6787321 (Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products) held by The Regents of the University of California expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/00, A61K48/0058, A61P, A61P35/00